VF
LUCD icon

Virtu Financial’s Lucid Diagnostics LUCD Stock Holding History

Virtu Financial’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,096
Closed -$31K – 1961
2026
Q1 		$31K Buy
+27,096
New +$34.5K ﹤0.01% 1349
2025
Q3 		– Sell
-11,332
Closed -$13K – 1818
2025
Q2 		$13K Buy
+11,332
New +$14.6K ﹤0.01% 1294
2024
Q3 		– Sell
-14,158
Closed -$12K – 1657
2024
Q2 		$12K Sell
14,158
-20,513
-59% -$17.4K ﹤0.01% 1110
2024
Q1 		$28K Buy
34,671
+13,835
+66% +$18K ﹤0.01% 1119
2023
Q4 		$29K Buy
+20,836
New +$27.5K ﹤0.01% 1260
2023
Q2 		– Sell
-15,545
Closed -$22K – 1809
2023
Q1 		$22K Buy
+15,545
New +$21.5K ﹤0.01% 1229
2022
Q1 		– Sell
-11,359
Closed -$61K – 1793
2021
Q4 		$61K Buy
+11,359
New +$92.2K 0.01% 1284

Other funds holding LUCD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Virtu Financial's LUCD Position: Q2 2026 in Review

Virtu Financial sold out of Lucid Diagnostics (LUCD) in Q2 2026, closing a stake of 27,096 shares — an estimated $31K sold.

Virtu Financial first reported a position in LUCD in Q4 2021 and held it in 7 quarters. The position peaked at $61K in Q4 2021. 86 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • Virtu Financial reported no remaining Lucid Diagnostics position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 27,096 Lucid Diagnostics shares in Q2 2026, an estimated $31K.
  • Virtu Financial first reported a position in Lucid Diagnostics in Q4 2021 and held it in 7 quarters.
  • Virtu Financial's Lucid Diagnostics position peaked at $61K in Q4 2021.
  • 86 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.